Cytochrome c oxidase assembly factor COX20 (COX20)

Cytochrome c oxidase assembly factor COX20 (COX20) is a mitochondrial transmembrane chaperone essential for the assembly of complex IV (cytochrome c oxidase) in human mitochondria[1][2][4]. The protein functions by stabilizing and presenting the newly synthesized COX2 subunit to metallochaperones (SCO1 and SCO2) during its maturation and incorporation into the holoenzyme complex, thereby facilitating oxidative phosphorylation and cellular respiration[1][2][3]. Mutations in the COX20 gene impair the formation and maintenance of complex IV, resulting in mitochondrial complex IV deficiency, which manifests as early-onset and progressive neuromuscular disorders (ataxia, hypotonia, muscle weakness, neuropathy, cognitive impairment, and multi-organ involvement)[2][3][4]. Disease inheritance is autosomal recessive, with cases predominantly reported in pediatric populations. No targeted pharmacotherapies exist for COX20-related disease, and management is limited to supportive care and nutritional supplementation[3]. COX20 interacts with other mitochondrial proteins (COX2, TMEM177, SCO1, COA6), but no known drugs directly target its function[1][4]. Detection of pathogenic variants serves as a diagnostic biomarker and is essential for genetic counseling and prenatal testing in affected families[3].

Other names

Cytochrome c oxidase assembly protein COX20, mitochondrialCOX20FAM36AFLJ43269MC4DN11Cytochrome c oxidase protein 20 homologCox2 chaperone homologFamily with sequence similarity 36, member A